United States · FDA National Drug Code directory

HYDROCHLOROTHIAZIDE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
23155-008_a1057270-4261-4cac-bc26-2dbffb13eacb
Product NDC
23155-008
Form
TABLET
Composition / generic term
hydrochlorothiazide
Labeler
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Marketing category
ANDA
Marketing start / end (source format)
20150115
Source listing expiry
20261231

Source-listed ingredients

  • HYDROCHLOROTHIAZIDE — 25 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET in 1 BOTTLE (23155-008-01) · 23155-008-01
  • 500 TABLET in 1 BOTTLE (23155-008-05) · 23155-008-05
  • 1000 TABLET in 1 BOTTLE (23155-008-10) · 23155-008-10
  • 5000 TABLET in 1 BOTTLE (23155-008-18) · 23155-008-18

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →